Propranolol Dose Escalation in Lymphedema in Patients

Summary

This is a study to investigate the safety and efficacy of propranolol in the treatment of patients with primary lymphedema. The primary goal is to assess patient tolerability of increasing doses of propranolol. The secondary goal is to assess lymphedema symptoms and signs in response to propranolol treatment.

Timeline

Start

2017-06-07

Primary completion

2020-10-08

Completion

2020-10-08

Drugs

Indications